|
| Press Releases |
|
 |
|
| Tuesday, June 12, 2018 |
|
|
Novotech Signs MOU with China Medical University Hospital in Taiwan to Offer Enhanced Services for Global Trials |
| Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with the China Medical University Hospital (CMUH) in Taiwan to facilitate high-quality and rapid feasibility, start-up and recruitment processes. http://www.cmuh.cmu.edu.tw/ more info >> |
|
| Friday, May 18, 2018 |
|
|
Novotech稱，聯邦預算研發稅收扶持使澳大利亞在高質量臨床試驗方面具有全球競爭力 |
| 亞太地區首席技術官對特恩布爾政府的聯邦預算決定表示讚賞。該決定將臨床試驗活動排除在400萬美元的現金退款限製或最大封頂限額之外。 more info >> |
|
|
Novotech称，联邦预算研发税收扶持使澳大利亚在高质量临床试验方面具有全球竞争力 |
| 亚太地区首席技术官对特恩布尔政府的联邦预算决定表示赞赏。该决定将临床试验活动排除在400万美元的现金退款限制或最大封顶限额之外。 more info >> |
|
|
Novotech says Federal Budget R&D Tax Support Keeps Australia Globally Competitive for Quality Clinical Trials |
| Leading Asia Pacific CRO Novotech commended the Turnbull Government's Federal Budget decision to exclude clinical trials activity from a A$4m cap on cash refunds, or any lifetime cap on refunds. more info >> |
|
| Friday, June 23, 2017 |
|
|
Novotech signs Central Lab Services Agreement with Sonic Clinical Trials |
| Asia Pacific specialist CRO Novotech announced today it has expanded its business offering to include central lab services through a preferred partnership agreement with Sonic Clinical Trials, an affiliate of international healthcare company, Sonic Healthcare. more info >> |
|
| Thursday, April 20, 2017 |
|
|
諾泰與韓國領先醫療中心（峨山醫療中心）簽署諒解備忘錄 |
| 亞太地區專家合同研究組織諾泰今日宣布，其已經與韓國最大的醫療機構——峨山醫療中心（AMC）的臨床研究中心簽署了諒解備忘錄（MOU）。該諒解備忘錄正式確定了諾泰與國際領先醫療中心及其主要研究者之間的關係。 more info >> |
|
|
诺泰与韩国领先医疗中心（峨山医疗中心）签署谅解备忘录 |
| 亚太地区专家合同研究组织诺泰今日宣布，其已经与韩国最大的医疗机构——峨山医疗中心（AMC）的临床研究中心签署了谅解备忘录（MOU）。该谅解备忘录正式确定了诺泰与国际领先医疗中心及其主要研究者之间的关系。 more info >> |
|
| Tuesday, April 18, 2017 |
|
|
노보테크, 韓 최대 의료기관 서울아산병원과 MoU 체결 |
| 아시아태평양 전문 임상시험수탁기관(CRO) 노보테크(Novotech)가 한국 최대 의료기관인 서울아산병원 임상시험센터와 MoU를 체결했다. 이로써 노보테크는 국제적으로 명망 높은 의료기관 및 그 산하의 핵심 연구소와 공식적인 파트너십을 맺게 됐다. more info >> |
|
|
Novotech signs MOU with South Korea's leading medical center, the Asan Medical Center |
| Asia Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with South Korea's largest medical institution - The Asan Medical Center's (AMC) Clinical Trial Center. The MOU formalises Novotech's relationship with the internationally-leading medical center and its principal investigators. more info >> |
|
| Thursday, March 9, 2017 |
|
|
New Research reveals Asia poised as Preferred Destination for Clinical Trials |
| Frost & Sullivan released a white paper, 'Asia: Preferred Destination for Clinical Trials', with Asia Pacific CRO Novotech presenting the findings to an audience of senior biotechnology and pharmaceutical executives in a private event at the Outsourcing in Clinical Trials - West Coast (OCT-WC 2017) conference, held Feb 22-23 in Burlingame, Ca. (USA). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
SAP商業AI持續釋放數據價值 驅動企業韌性增長
Jun 13, 2025 13:10 HKT/SGT
|
|
|
Ria Money Transfer's New Approval Enables Digital Salary Payments for Malaysia's Migrant Workforce
Jun 13, 2025 13:00: JST
|
|
|
ARE Expands India Leadership, Strengthens Regional Role in Climate, Energy, and Food System Transition
Jun 13, 2025 12:46: JST
|
|
|
Ria Money Transfer's New Approval Enables Digital Salary Payments for Malaysia's Migrant Workforce
Jun 13, 2025 12:00 HKT/SGT
|
|
|
TRENDE Announces Strategic Capital and Business Alliance with Tokyu Land
Jun 13, 2025 13:00 JST
|
|
|
ARE Expands India Leadership, Strengthens Regional Role in Climate, Energy, and Food System Transition
Jun 13, 2025 11:46 HKT/SGT
|
|
|
JBM Healthcare Delivers Strong FY2025 Annual Results, Net Profit Surged 51.2% to HK$197.3 Million
Jun 12, 2025 21:07 HKT/SGT
|
|
|
健倍苗苗二零二五財年全年業績表現亮眼 純利飆升51.2%至1.97億港元
Jun 12, 2025 20:58 HKT/SGT
|
|
|
健倍苗苗二零二五财年全年业绩表现亮眼 纯利飙升51.2%至1.97亿港元
Jun 12, 2025 20:48 HKT/SGT
|
|
|
品質基石的守護者：檢測檢驗行業賦能高質量發展
Jun 12, 2025 18:28 HKT/SGT
|
|
|
质量基石的守护者：检测检验行业赋能高质量发展
Jun 12, 2025 18:19 HKT/SGT
|
|
|
NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances
Jun 12, 2025 17:38: JST
|
|
|
NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances
Jun 12, 2025 16:38 HKT/SGT
|
|
|
耐賦康(R)與EVER001協同發力 雲頂新耀推動腎病治療進入精準管理新階段
Jun 12, 2025 16:31 HKT/SGT
|
|
|
耐赋康(R)与EVER001协同发力 云顶新耀推动肾病治疗进入精准管理新阶段
Jun 12, 2025 16:26 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
